Delivery Order SPE2DB24D2010-SPE2DB25FZUQ5

Award Date 1/21/25
Potential Completion Date 1/22/25
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.85 firm-fixed-price contract is for the provision of CIMZIA 2X200 MG/ML syringe kits. This order is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a firm fixed price ceiling value of $13,245.88 and an ultimate completion date of October 31, 2023. This order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $8,472.36 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of CIMZIA 2X200 MG/ML syringe kits, a specialty medication used for various therapeutic applications. The contract has an ultimate completion date of December 17, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a $12,646.06 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567139686 units of CIMZIA 2X200 MG/ML SYRINGE KITS, a specialty medication, with an ultimate completion date of February 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $20,181.37, is for the delivery of 4560594952 CIMZIA 2X200 MG/ML syringe kits. The order has an ultimate completion date of April 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,706.59, is for the provision of CIMZIA 2X200 MG/ML syringe kits. The contract is a firm fixed-price delivery order with an ultimate completion date of April 27, 2023. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,061.06, is for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract has a firm fixed price pricing type and is set to be completed by February 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $24,693.30, is for the supply of CIMZIA 2X200 MG/ML syringe kits, a specialty medication used for various medical conditions. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price delivery order, indicating a pre-established pricing structure. The contract is not designated as a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $24,594.97 firm fixed-price contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a period of performance through February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,397.12, is for the supply of CIMZIA 2X200 MG/ML syringe kits, which are likely a specialized medication used for various medical conditions. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price delivery order. This contract award is not...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZUQ5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,889.46 firm fixed-price contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, with a completion date of January 22, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/21/25, 10:08 AM